Carl Zeiss Meditec AG (AFX.DE)
EUR 59.8
(-0.5%)
EUR 59.8
(-0.5%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 290.39 Million EUR | -1.2% |
| 2022 | 293.9 Million EUR | 24.39% |
| 2021 | 236.27 Million EUR | 93.06% |
| 2020 | 122.38 Million EUR | -23.39% |
| 2019 | 159.75 Million EUR | 26.33% |
| 2018 | 126.46 Million EUR | -5.94% |
| 2017 | 134.44 Million EUR | 36.73% |
| 2016 | 98.33 Million EUR | 57.84% |
| 2015 | 62.29 Million EUR | -16.89% |
| 2014 | 74.95 Million EUR | -19.84% |
| 2013 | 93.5 Million EUR | 30.1% |
| 2012 | 71.87 Million EUR | -0.56% |
| 2011 | 72.27 Million EUR | 21.19% |
| 2010 | 59.63 Million EUR | 8.23% |
| 2009 | 55.1 Million EUR | -2.03% |
| 2008 | 56.24 Million EUR | 17.76% |
| 2007 | 47.75 Million EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 46.47 Million EUR | 24.27% |
| 2024 Q3 | 34.13 Million EUR | -26.57% |
| 2024 Q1 | 37.4 Million EUR | -56.1% |
| 2023 Q4 | 85.19 Million EUR | -7.55% |
| 2023 FY | 290.39 Million EUR | -1.2% |
| 2023 Q1 | 51 Million EUR | -50.35% |
| 2023 Q2 | 62 Million EUR | 21.57% |
| 2023 Q3 | 92.15 Million EUR | 48.62% |
| 2022 Q1 | 37.9 Million EUR | -29.91% |
| 2022 Q4 | 102.7 Million EUR | 64.25% |
| 2022 Q3 | 62.53 Million EUR | -31.08% |
| 2022 Q2 | 90.72 Million EUR | 139.39% |
| 2022 FY | 293.9 Million EUR | 24.39% |
| 2021 Q1 | 46.3 Million EUR | -12.95% |
| 2021 FY | 236.27 Million EUR | 93.06% |
| 2021 Q3 | 81.58 Million EUR | 50.23% |
| 2021 Q4 | 54.07 Million EUR | -33.72% |
| 2021 Q2 | 54.3 Million EUR | 17.3% |
| 2020 Q1 | 38.8 Million EUR | -23.71% |
| 2020 Q3 | 5.29 Million EUR | -78.92% |
| 2020 Q4 | 53.18 Million EUR | 905.39% |
| 2020 FY | 122.38 Million EUR | -23.39% |
| 2020 Q2 | 25.09 Million EUR | -35.33% |
| 2019 Q1 | 28.7 Million EUR | -35.6% |
| 2019 FY | 159.75 Million EUR | 26.33% |
| 2019 Q3 | 50.82 Million EUR | 72.92% |
| 2019 Q2 | 29.39 Million EUR | 2.4% |
| 2019 Q4 | 50.85 Million EUR | 0.07% |
| 2018 Q3 | 25.86 Million EUR | -6.18% |
| 2018 FY | 126.46 Million EUR | -5.94% |
| 2018 Q4 | 44.56 Million EUR | 72.26% |
| 2018 Q2 | 27.57 Million EUR | -3.26% |
| 2018 Q1 | 28.5 Million EUR | -32.05% |
| 2017 FY | 134.44 Million EUR | 36.73% |
| 2017 Q3 | 30.76 Million EUR | -0.4% |
| 2017 Q2 | 30.88 Million EUR | -0.05% |
| 2017 Q1 | 30.9 Million EUR | 1.14% |
| 2017 Q4 | 41.94 Million EUR | 36.35% |
| 2016 Q1 | 16.72 Million EUR | 67.26% |
| 2016 Q4 | 30.55 Million EUR | 54.45% |
| 2016 Q3 | 19.78 Million EUR | -36.75% |
| 2016 Q2 | 31.27 Million EUR | 87.03% |
| 2016 FY | 98.33 Million EUR | 57.84% |
| 2015 Q2 | 11.73 Million EUR | -35.97% |
| 2015 Q3 | 22.23 Million EUR | 89.5% |
| 2015 Q4 | 9.99 Million EUR | -55.05% |
| 2015 FY | 62.29 Million EUR | -16.89% |
| 2015 Q1 | 18.32 Million EUR | 4.77% |
| 2014 Q3 | 17.98 Million EUR | -7.15% |
| 2014 Q2 | 19.37 Million EUR | -3.6% |
| 2014 FY | 74.95 Million EUR | -19.84% |
| 2014 Q1 | 20.09 Million EUR | -26.58% |
| 2014 Q4 | 17.49 Million EUR | -2.76% |
| 2013 Q4 | 27.37 Million EUR | 14.62% |
| 2013 Q2 | 18.88 Million EUR | -19.19% |
| 2013 Q1 | 23.36 Million EUR | 55.5% |
| 2013 FY | 93.5 Million EUR | 30.1% |
| 2013 Q3 | 23.88 Million EUR | 26.49% |
| 2012 FY | 71.87 Million EUR | -0.56% |
| 2012 Q3 | 14.07 Million EUR | -43.27% |
| 2012 Q4 | 15.02 Million EUR | 6.79% |
| 2012 Q2 | 24.8 Million EUR | 38.01% |
| 2012 Q1 | 17.97 Million EUR | -8.09% |
| 2011 Q1 | 14.58 Million EUR | -37.06% |
| 2011 Q4 | 19.55 Million EUR | 15.95% |
| 2011 Q3 | 16.86 Million EUR | -20.72% |
| 2011 FY | 72.27 Million EUR | 21.19% |
| 2011 Q2 | 21.27 Million EUR | 45.79% |
| 2010 Q1 | 12.56 Million EUR | -33.37% |
| 2010 Q3 | 11.34 Million EUR | -9.63% |
| 2010 Q2 | 12.55 Million EUR | -0.09% |
| 2010 Q4 | 23.18 Million EUR | 104.38% |
| 2010 FY | 59.63 Million EUR | 8.23% |
| 2009 FY | 55.1 Million EUR | -2.03% |
| 2009 Q4 | 18.85 Million EUR | 89.14% |
| 2009 Q3 | 9.96 Million EUR | -19.44% |
| 2009 Q2 | 12.37 Million EUR | -11.03% |
| 2009 Q1 | 13.9 Million EUR | 0.0% |
| 2008 FY | 56.24 Million EUR | 17.76% |
| 2007 FY | 47.75 Million EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 151.84 Million EUR | -91.249% |
| Fielmann Aktiengesellschaft | 127.64 Million EUR | -127.505% |
| Gerresheimer AG | 116.12 Million EUR | -150.07% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | -41.519% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | -41.519% |